AI Article Synopsis
- Some studies indicate that antioxidants can help with chemotherapy side effects and overall response to treatment.
- This study focused on whether a single dose of oral glutamine could protect against clastogenicity caused by the chemotherapy drug cisplatin in rats.
- Results showed that glutamine significantly reduced the clastogenicity (by about 48%) in rat bone marrow, suggesting its antioxidant properties may help lessen the harmful effects of cisplatin.
Article Abstract
Several studies have suggested that dietary supplementation with antioxidants can influence the response to chemotherapy as well as the development of adverse side effects that result from treatment with antineoplastic agents. The emphasis of the present study was to investigate whether the administration of a single dose of oral glutamine had any protective effect against cisplatin-induced clastogenicity. Cisplatin was administered to Wistar rats either alone or after treatment with glutamine. The rats were treated with glutamine (300 mg/kg b.w.) by gavage 24h before the administration of cisplatin (5mg/kg b.w., i.p.) and then sacrificed 24h after treatment with cisplatin. Glutamine significantly reduced (by about 48%) the clastogenicity of cisplatin in rat bone marrow cells. The antioxidant action of glutamine presumably modulates the clastogenic action of cisplatin.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s1383-5718(02)00074-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!